Correlation Between Pfizer and Innovator Growth
Can any of the company-specific risk be diversified away by investing in both Pfizer and Innovator Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Innovator Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Innovator Growth 100 Power, you can compare the effects of market volatilities on Pfizer and Innovator Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Innovator Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Innovator Growth.
Diversification Opportunities for Pfizer and Innovator Growth
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and Innovator is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Innovator Growth 100 Power in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Growth 100 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Innovator Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Growth 100 has no effect on the direction of Pfizer i.e., Pfizer and Innovator Growth go up and down completely randomly.
Pair Corralation between Pfizer and Innovator Growth
Considering the 90-day investment horizon Pfizer is expected to generate 1.21 times less return on investment than Innovator Growth. In addition to that, Pfizer is 4.11 times more volatile than Innovator Growth 100 Power. It trades about 0.03 of its total potential returns per unit of risk. Innovator Growth 100 Power is currently generating about 0.15 per unit of volatility. If you would invest 4,723 in Innovator Growth 100 Power on August 28, 2024 and sell it today you would earn a total of 391.00 from holding Innovator Growth 100 Power or generate 8.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Innovator Growth 100 Power
Performance |
| Timeline |
| Pfizer Inc |
| Innovator Growth 100 |
Pfizer and Innovator Growth Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Innovator Growth
The main advantage of trading using opposite Pfizer and Innovator Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Innovator Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Growth will offset losses from the drop in Innovator Growth's long position.| Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
| Innovator Growth vs. Innovator Nasdaq 100 Power | Innovator Growth vs. Innovator Nasdaq 100 Power | Innovator Growth vs. Innovator SP 500 | Innovator Growth vs. Innovator SP 500 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |